PANADOL by is a Otc medication manufactured, distributed, or labeled by GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. Drug facts, warnings, and ingredients follow.
Liver warning: This product contains acetaminophen. Severe liver damage may occur if you take
Allergy alert: A‑cetaminophen may cause severe skin reactions. Symptoms may include:
If a skin reaction occurs, stop use and seek medical help right away.
NDC: 0135-0609-01
PANADOL
EXTRA STRENGTH
500
ACETAMINOPHEN
Pain Reliever
Fever Reducer
24 CAPLETS
Trademarks are owned by or licensed to the GSK group of companies.
Tamper-Evident Feature: Do not use if printed bottle seal (under cap) is missing or broken.
READ AND KEEP CARTON FOR COMPLETE INFORMATION
Distributed by:
GSK Consumer Healthcare, Warren, NJ 07059
©2016 GSK group of companies or its licensor.
101596D
| PANADOL 		
					EXTRA STRENGTH acetaminophen tablet, film coated | ||||||||||||||||||||||||||||||||||||||||||||||||||
| 
 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| 
 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| 
 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| 
 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| 
 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| 
 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Labeler - GlaxoSmithKline Consumer Healthcare Holdings (US) LLC (079944263) | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  PANADOL  98688417  not registered Live/Pending | Haleon UK IP Limited 2024-08-08 | 
|  PANADOL  98675464  not registered Live/Pending | Haleon UK IP Limited 2024-07-31 | 
|  PANADOL  87707023  5512890 Live/Registered | GlaxoSmithKline Consumer Healthcare (UK) IP Limited 2017-12-04 | 
|  PANADOL  85678959  4408281 Live/Registered | GLAXOSMITHKLINE CONSUMER HEALTHCARE (UK) IP LIMITED 2012-07-17 | 
|  PANADOL  73094226  1060597 Live/Registered | STERLING DRUG INC. 1976-07-22 |